Novel findings on anti-plaque effects of stannous fluoride
To evaluate the antiplaque effects for 0.454% bioavailable gluconate chelated stannous fluoride (SnF₂) dentifrices versus controls by clinical model, plaque index, tooth surface and tooth type in a pooled analysis. Randomized controlled trials (RCTs) were conducted to evaluate plaque effects of SnF₂...
Gespeichert in:
| Veröffentlicht in: | American journal of dentistry Jg. 35; H. 6; S. 297 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.12.2022
|
| Schlagworte: | |
| ISSN: | 0894-8275 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | To evaluate the antiplaque effects for 0.454% bioavailable gluconate chelated stannous fluoride (SnF₂) dentifrices versus controls by clinical model, plaque index, tooth surface and tooth type in a pooled analysis.
Randomized controlled trials (RCTs) were conducted to evaluate plaque effects of SnF₂ dentifrices from the same formulation family over the past 30 years. Forty-four 4-day and longer-term (≥ 2 weeks) RCTs conducted in six countries with 3,336 subjects using Turesky Modified Quigley-Hein Plaque Index, Rustogi Modification of the Navy Plaque Index, Digital Plaque Imaging Analysis, and Silness and Löe Plaque Index were included.
In 13 and 11 longer-term studies assessing SnF₂ dentifrice versus a negative or positive control, respectively, standardized differences in average plaque score of -1.15 (95% CI: -1.61, -0.69) and -0.74 (95% CI: -1.20, -0.28) were observed (P ≤ 0.011), favoring SnF₂. Reductions represented a 19% and 16% benefit versus the negative and positive control, respectively. In 18 and five 4-day studies assessing SnF₂ dentifrice versus a negative (NaF/SMFP) or positive (triclosan/chlorhexidine) control, respectively, differences in average 4-day plaque score of -0.27 (95% CI: -0.31, -0.23) and -0.15 (95% CI: -0.25, -0.06) were observed (P≤ 0.001) favoring SnF₂. Reductions represented a 14% and 11% benefit versus the negative and positive control, respectively. Significant antiplaque benefits for SnF₂ dentifrice were seen regardless of clinical model, plaque index, tooth surface or type, including brushed and unbrushed surfaces (P≤ 0.049).
Bioavailable gluconate chelated SnF₂ dentifrices showed consistent plaque inhibition versus negative and positive controls across all conditions evaluated. Importantly, the effect on unbrushed surfaces illustrated the significant plaque inhibition benefit of SnF₂ beyond mechanical plaque removal. |
|---|---|
| AbstractList | To evaluate the antiplaque effects for 0.454% bioavailable gluconate chelated stannous fluoride (SnF₂) dentifrices versus controls by clinical model, plaque index, tooth surface and tooth type in a pooled analysis.
Randomized controlled trials (RCTs) were conducted to evaluate plaque effects of SnF₂ dentifrices from the same formulation family over the past 30 years. Forty-four 4-day and longer-term (≥ 2 weeks) RCTs conducted in six countries with 3,336 subjects using Turesky Modified Quigley-Hein Plaque Index, Rustogi Modification of the Navy Plaque Index, Digital Plaque Imaging Analysis, and Silness and Löe Plaque Index were included.
In 13 and 11 longer-term studies assessing SnF₂ dentifrice versus a negative or positive control, respectively, standardized differences in average plaque score of -1.15 (95% CI: -1.61, -0.69) and -0.74 (95% CI: -1.20, -0.28) were observed (P ≤ 0.011), favoring SnF₂. Reductions represented a 19% and 16% benefit versus the negative and positive control, respectively. In 18 and five 4-day studies assessing SnF₂ dentifrice versus a negative (NaF/SMFP) or positive (triclosan/chlorhexidine) control, respectively, differences in average 4-day plaque score of -0.27 (95% CI: -0.31, -0.23) and -0.15 (95% CI: -0.25, -0.06) were observed (P≤ 0.001) favoring SnF₂. Reductions represented a 14% and 11% benefit versus the negative and positive control, respectively. Significant antiplaque benefits for SnF₂ dentifrice were seen regardless of clinical model, plaque index, tooth surface or type, including brushed and unbrushed surfaces (P≤ 0.049).
Bioavailable gluconate chelated SnF₂ dentifrices showed consistent plaque inhibition versus negative and positive controls across all conditions evaluated. Importantly, the effect on unbrushed surfaces illustrated the significant plaque inhibition benefit of SnF₂ beyond mechanical plaque removal. To evaluate the antiplaque effects for 0.454% bioavailable gluconate chelated stannous fluoride (SnF₂) dentifrices versus controls by clinical model, plaque index, tooth surface and tooth type in a pooled analysis.PURPOSETo evaluate the antiplaque effects for 0.454% bioavailable gluconate chelated stannous fluoride (SnF₂) dentifrices versus controls by clinical model, plaque index, tooth surface and tooth type in a pooled analysis.Randomized controlled trials (RCTs) were conducted to evaluate plaque effects of SnF₂ dentifrices from the same formulation family over the past 30 years. Forty-four 4-day and longer-term (≥ 2 weeks) RCTs conducted in six countries with 3,336 subjects using Turesky Modified Quigley-Hein Plaque Index, Rustogi Modification of the Navy Plaque Index, Digital Plaque Imaging Analysis, and Silness and Löe Plaque Index were included.METHODSRandomized controlled trials (RCTs) were conducted to evaluate plaque effects of SnF₂ dentifrices from the same formulation family over the past 30 years. Forty-four 4-day and longer-term (≥ 2 weeks) RCTs conducted in six countries with 3,336 subjects using Turesky Modified Quigley-Hein Plaque Index, Rustogi Modification of the Navy Plaque Index, Digital Plaque Imaging Analysis, and Silness and Löe Plaque Index were included.In 13 and 11 longer-term studies assessing SnF₂ dentifrice versus a negative or positive control, respectively, standardized differences in average plaque score of -1.15 (95% CI: -1.61, -0.69) and -0.74 (95% CI: -1.20, -0.28) were observed (P ≤ 0.011), favoring SnF₂. Reductions represented a 19% and 16% benefit versus the negative and positive control, respectively. In 18 and five 4-day studies assessing SnF₂ dentifrice versus a negative (NaF/SMFP) or positive (triclosan/chlorhexidine) control, respectively, differences in average 4-day plaque score of -0.27 (95% CI: -0.31, -0.23) and -0.15 (95% CI: -0.25, -0.06) were observed (P≤ 0.001) favoring SnF₂. Reductions represented a 14% and 11% benefit versus the negative and positive control, respectively. Significant antiplaque benefits for SnF₂ dentifrice were seen regardless of clinical model, plaque index, tooth surface or type, including brushed and unbrushed surfaces (P≤ 0.049).RESULTSIn 13 and 11 longer-term studies assessing SnF₂ dentifrice versus a negative or positive control, respectively, standardized differences in average plaque score of -1.15 (95% CI: -1.61, -0.69) and -0.74 (95% CI: -1.20, -0.28) were observed (P ≤ 0.011), favoring SnF₂. Reductions represented a 19% and 16% benefit versus the negative and positive control, respectively. In 18 and five 4-day studies assessing SnF₂ dentifrice versus a negative (NaF/SMFP) or positive (triclosan/chlorhexidine) control, respectively, differences in average 4-day plaque score of -0.27 (95% CI: -0.31, -0.23) and -0.15 (95% CI: -0.25, -0.06) were observed (P≤ 0.001) favoring SnF₂. Reductions represented a 14% and 11% benefit versus the negative and positive control, respectively. Significant antiplaque benefits for SnF₂ dentifrice were seen regardless of clinical model, plaque index, tooth surface or type, including brushed and unbrushed surfaces (P≤ 0.049).Bioavailable gluconate chelated SnF₂ dentifrices showed consistent plaque inhibition versus negative and positive controls across all conditions evaluated. Importantly, the effect on unbrushed surfaces illustrated the significant plaque inhibition benefit of SnF₂ beyond mechanical plaque removal.CLINICAL SIGNIFICANCEBioavailable gluconate chelated SnF₂ dentifrices showed consistent plaque inhibition versus negative and positive controls across all conditions evaluated. Importantly, the effect on unbrushed surfaces illustrated the significant plaque inhibition benefit of SnF₂ beyond mechanical plaque removal. |
| Author | Zou, Yuanshu Biesbrock, Aaron R DiGennaro, Joe He, Tao |
| Author_xml | – sequence: 1 givenname: Tao surname: He fullname: He, Tao organization: The Procter & Gamble Company, Mason, Ohio, USA – sequence: 2 givenname: Yuanshu surname: Zou fullname: Zou, Yuanshu organization: The Procter & Gamble Company, Mason, Ohio, USA – sequence: 3 givenname: Joe surname: DiGennaro fullname: DiGennaro, Joe organization: The Procter & Gamble Company, Mason, Ohio, USA – sequence: 4 givenname: Aaron R surname: Biesbrock fullname: Biesbrock, Aaron R email: biesbrock.ar@pg.com organization: The Procter & Gamble Company, Mason, Ohio, USA, biesbrock.ar@pg.com |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36508185$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1j0tLxDAUhbMYcR76FyRLN4Xm1SbuZPAFg250XZLmXqlkktq0gv_egDOrA4ePw3e2ZBVThBXZ1NrISvNWrck256-6FqLR5pKsRaNqzbTakLvX9AOB4hD9ED8zTZHaOA_VGOz3AhQQoZ9LjTTPNsa0ZIphSdPg4YpcoA0Zrk-5Ix-PD-_75-rw9vSyvz9UI2dsriRnWvbKewTvlGw8B4a1dJqjs7oVrUDFeil7bPsalCkpHTcGJTrhHOM7cvu_O06pOOW5Ow65hxBshOLTlX-iaRqj24LenNDFHcF34zQc7fTbnf_yP1NiUoI |
| ContentType | Journal Article |
| Copyright | Copyright©American Journal of Dentistry. |
| Copyright_xml | – notice: Copyright©American Journal of Dentistry. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| ExternalDocumentID | 36508185 |
| Genre | Journal Article |
| GroupedDBID | --- 23M 53G 5GY 5RE AENEX AFFNX ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF F5P GK1 NPM P2P SJN ZE2 ZGI 7X8 |
| ID | FETCH-LOGICAL-p211t-42184c5ddfedb546d2e1f04b82fba87373f51c44cf7c0e59cf74b299f4fb3bb12 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000911061700004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0894-8275 |
| IngestDate | Sun Nov 09 12:25:20 EST 2025 Wed Feb 19 02:25:59 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | Copyright©American Journal of Dentistry. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-p211t-42184c5ddfedb546d2e1f04b82fba87373f51c44cf7c0e59cf74b299f4fb3bb12 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 36508185 |
| PQID | 2753666987 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2753666987 pubmed_primary_36508185 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-Dec 20221201 |
| PublicationDateYYYYMMDD | 2022-12-01 |
| PublicationDate_xml | – month: 12 year: 2022 text: 2022-Dec |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | American journal of dentistry |
| PublicationTitleAlternate | Am J Dent |
| PublicationYear | 2022 |
| SSID | ssj0033689 |
| Score | 2.350152 |
| SecondaryResourceType | review_article |
| Snippet | To evaluate the antiplaque effects for 0.454% bioavailable gluconate chelated stannous fluoride (SnF₂) dentifrices versus controls by clinical model, plaque... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 297 |
| SubjectTerms | Dental Plaque - drug therapy Dental Plaque - prevention & control Dental Plaque Index Dentifrices - therapeutic use Double-Blind Method Gingivitis Humans Sodium Fluoride Tin Fluorides - therapeutic use Triclosan |
| Title | Novel findings on anti-plaque effects of stannous fluoride |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36508185 https://www.proquest.com/docview/2753666987 |
| Volume | 35 |
| WOSCitedRecordID | wos000911061700004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LS8QwEMeDuh68-MDX-iKC12CbpG3qRURcvFj2oLC3kteIsLTVXffzO8l29SQIXtpT2zBJM7_JTPIn5MqKxEDqBFOpD1tyvGQahGPIysoZlYHSSRSbKKpKTSbluF9wm_Vllas5MU7UrrVhjfyaI1cjamOIfNu9s6AaFbKrvYTGOhkIRJkwqovJdxZBiDxK4CWqlEzxIvudIqM3Ge38tx27ZLvnSHq37Pg9suabfXJTtQs_pTEP3bzOaNtQNNwb66YaP0H72g3aAg1MGA5npTD9xLc7f0BeRg_P94-sF0dgHcZscyZDbGYz58A7k8nccZ9CIo3iYLQqRCEgS62UFgqb-KzEuzToe0CCEcak_JBsNG3jjwlVhc21sIkuHUiuc_TgXpciNdz5HIAPyeXKFDUOvpBR0I3HNtY_xhiSo6U96255SkYtAvshDZz84elTssXDtoJYJnJGBoC_nj8nm3Yxf5t9XMRexWs1fvoCnlSw6w |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+findings+on+anti-plaque+effects+of+stannous+fluoride&rft.jtitle=American+journal+of+dentistry&rft.au=He%2C+Tao&rft.au=Zou%2C+Yuanshu&rft.au=DiGennaro%2C+Joe&rft.au=Biesbrock%2C+Aaron+R&rft.date=2022-12-01&rft.issn=0894-8275&rft.volume=35&rft.issue=6&rft.spage=297&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0894-8275&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0894-8275&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0894-8275&client=summon |